Moclobemid 1 A Pharma (Moclobemide)

• Moclobemide is used to manage mood and anxiety disorders by increasing central monoamine levels.
• Major depressive disorder: reduces depressive symptoms and improves overall mood.
• Social anxiety disorder: lessens anxiety in social situations and enhances functional performance.
• Depressive symptoms associated with other psychiatric conditions: provides adjunctive relief when standard therapies are insufficient.

• Moclobemide reversibly inhibits monoamine oxidase A (MAO‑A), the enzyme responsible for breaking down serotonin, norepinephrine, and dopamine. By blocking MAO‑A, the drug raises synaptic concentrations of these neurotransmitters, thereby enhancing mood regulation and reducing anxiety without permanent enzyme inactivation.

Moclobemide may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Nausea
• Headache
• Insomnia or somnolence
• Dizziness
• Dry mouth
• Constipation

Serious or Rare Side Effects

• Hypertensive crisis, especially with tyramine‑rich foods
• Serotonin syndrome when combined with other serotonergic agents
• Severe liver injury
• Life‑threatening skin reactions (e.g., Stevens‑Johnson syndrome)
• Agranulocytosis
• Emergence of suicidal thoughts or behaviors

• Before prescribing Moclobemide, clinicians should consider several safety measures.
• Assess hepatic function: evaluate liver enzymes prior to initiation.
• Monitor blood pressure: advise avoidance of tyramine‑rich foods to prevent hypertensive episodes.
• Screen psychiatric history: watch for worsening depression or suicidal ideation.
• Avoid abrupt discontinuation: taper under medical supervision to reduce withdrawal risk.
• Pregnancy and lactation: safety not established; use only if benefits outweigh potential risks.
• Store at ambient temperature: keep in the original container, protect from moisture and light.

Moclobemide interacts with several drug classes; some combinations must be avoided while others require close monitoring.

Major Interactions (Avoid)

• Tyramine‑rich foods: risk of hypertensive crisis.
• Selective serotonin reuptake inhibitors (SSRIs): potential serotonin syndrome.
• Other MAO inhibitors: severe hypertension.
• Sympathomimetic agents (e.g., phenylephrine): elevated blood pressure.
• St. John’s wort: increased serotonin toxicity.

Moderate Interactions (Monitor Closely)

• Tricyclic antidepressants: may amplify serotonergic effects.
• Linezolid: risk of serotonin syndrome.
• Meperidine: potential serotonin toxicity.
• Decongestants (pseudoephedrine): may raise blood pressure.
• Antihypertensives: possible reduction in therapeutic effect.